Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Best Research Peptides for Rheumatoid Arthritis: Feature Comparison

Understanding how research peptides differ in mechanism, administration, and evidence base helps researchers and clinicians select compounds aligned with specific study objectives or patient profiles. BPC-157 NF-κB inhibition, angiogenesis, collagen synthesis

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Understanding how research peptides differ in mechanism, administration, and evidence base helps researchers and clinicians select compounds aligned with specific study objectives or patient profiles.
  • BPC-157
  • NF-κB inhibition, angiogenesis, collagen synthesis
  • Subcutaneous, oral
  • High. Multiple RA models show 50–62% reduction in joint swelling
  • Only peptide with published gut barrier repair + joint protection data
  • Best first-choice research peptide for RA due to dual anti-inflammatory and regenerative profile
  • TB-500
  • VEGF upregulation, fibroblast activation, MMP modulation
  • Subcutaneous
  • Moderate. Cartilage protection shown in adjuvant arthritis models
  • Strongest angiogenic signal; ideal for erosive disease
  • Pairs well with BPC-157 for combined inflammation control and tissue repair
  • Thymosin Alpha-1
  • Treg modulation, dendritic cell maturation
  • Moderate. Autoimmune hepatitis and viral studies; limited RA-specific data
  • Only peptide targeting immune tolerance rather than suppression
  • Consider for patients with autoantibody-driven disease or failed DMARD response
  • GHRP-2
  • Growth hormone secretagogue, IGF-1 elevation
  • Low. No direct RA studies; GH/IGF-1 effects on cartilage well-documented
  • Hormonal approach to cartilage repair; systemic effects
  • Use cautiously; requires monitoring for GH-related side effects
  • MK-677
  • Oral GH secretagogue, IGF-1 elevation
  • Oral
  • Low. Popular in muscle wasting research; no RA trials
  • Oral bioavailability advantage
  • Convenient but less targeted than injectable peptides